A carregar...
P11.34 Bone Morphogenetic Protein 4 can sensitize glioblastoma cells to temozolomide
BACKGROUND: Glioblastoma (GBM) is the most prevalent and lethal primary brain tumor. Its recurrence and resistance to current therapies, i.e. temozolomide (TMZ), is thought to result from a subpopulation of cells exhibiting stem cell properties, called glioblastoma stem-like cells (GSCs). Bone Morph...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6796144/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.180 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|